Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical Features of Eosinophilic Esophagitis: A Single Center Experience in Ecuador

  • Received : 2022.01.05
  • Accepted : 2022.05.19
  • Published : 2022.07.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Data on eosinophilic esophagitis (EoE) in South America is scarce. Moreover, no studies are available in Ecuador. We evaluated the clinical, endoscopic, and histological characteristics of Ecuadorian children with EoE. Methods: Medical records of 2,711 children who underwent upper gastrointestinal endoscopy (UGE) between 2009 and 2020 at Hospital Metropolitano de Quito, Ecuador were reviewed. Esophageal mucosal biopsies were obtained from 72 patients and the features of 35 children with EoE were described. EoE was diagnosed when there were more than 15 eosinophils in the esophagus, per high power field. Results: EoE was diagnosed in 35 children (9.4±4.5 years) with a male predominance (74%). Abdominal pain (51.4%) and vomiting (31.4%) were dominant symptoms. A history of allergic diseases was noted in 47.1% of the children, which mainly included allergic rhinitis (37.1%) and atopic dermatitis (11.4%). The most common endoscopic findings were furrowing (82.9%) and edema (74.3%). All patients were initially treated with proton-pump inhibitors (PPIs). Those who did not respond to PPIs received steroids (5.7%) and diet therapy (5.7%), and five patients were referred to an allergist. Clinical and histological resolution was observed in 65% of the patients who underwent a second UGE after 6-8 weeks of PPI. Conclusion: Our study describes the clinical features of pediatric EoE in Ecuador. This is the first retrospective study in Ecuador that describes the clinical, endoscopic, and histological manifestations of EoE in a small pediatric population. Almost half of the children who underwent a biopsy had EoE.

Keywords

References

  1. Iuliano S, Minelli R, Vincenzi F, Gaiani F, Ruberto C, Leandro G, et al. Eosinophilic esophagitis in pediatric age, state of the art and review of the literature. Acta Biomed 2018;89(8-S):20-6.
  2. Rossetti D, Isoldi S, Oliva S. Eosinophilic esophagitis: update on diagnosis and treatment in pediatric patients. Paediatr Drugs 2020;22:343-56. https://doi.org/10.1007/s40272-020-00398-z
  3. De Matteis A, Pagliaro G, Corleto VD, Pacchiarotti C, Di Giulio E, Villa MP, et al. Eosinophilic esophagitis in children: clinical findings and diagnostic approach. Curr Pediatr Rev 2020;16:206-14.
  4. Attwood SE, Furuta GT. Eosinophilic esophagitis: historical perspective on an evolving disease. Gastroenterol Clin North Am 2014;43:185-99. https://doi.org/10.1016/j.gtc.2014.02.010
  5. Cavalli E, Brusaferro A, Pieri ES, Cozzali R, Farinelli E, De' Angelis GL, et al. Eosinophilic esophagitis in children: doubts and future perspectives. J Transl Med 2019;17:262. https://doi.org/10.1186/s12967-019-2014-0
  6. Markowitz JE, Clayton SB. Eosinophilic esophagitis in children and adults. Gastrointest Endosc Clin N Am 2018;28:59-75. https://doi.org/10.1016/j.giec.2017.07.004
  7. Attwood SE. Overview of eosinophilic oesophagitis. Br J Hosp Med (Lond) 2019;80:132-8. https://doi.org/10.12968/hmed.2019.80.3.132
  8. Gonzalez-Cervera J, Arias A, Redondo-Gonzalez O, Cano-Mollinedo MM, Terreehorst I, Lucendo AJ. Association between atopic manifestations and eosinophilic esophagitis: a systematic review and meta-analysis. Ann Allergy Asthma Immunol 2017;118:582-90.e2. https://doi.org/10.1016/j.anai.2017.02.006
  9. Bolton SM, Kagalwalla AF, Wechsler JB. Eosinophilic esophagitis in children: endoscopic findings at diagnosis and post-intervention. Curr Gastroenterol Rep 2018;20:4. https://doi.org/10.1007/s11894-018-0607-z
  10. Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference. Gastroenterology 2018;155:1022-33.e10. https://doi.org/10.1053/j.gastro.2018.07.009
  11. Lucendo AJ, Arias A, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016;14:13-22.e1. https://doi.org/10.1016/j.cgh.2015.07.041
  12. Laserna-Mendieta EJ, Casabona S, Guagnozzi D, Savarino E, Perello A, Guardiola-Arevalo A, et al. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry. Aliment Pharmacol Ther 2020;52:798-807. https://doi.org/10.1111/apt.15957
  13. Okimoto E, Ishimura N, Ishihara S. Clinical characteristics and treatment outcomes of patients with eosinophilic esophagitis and eosinophilic gastroenteritis. Digestion 2021;102:33-40. https://doi.org/10.1159/000511588
  14. Reddy A, Ashat D, Murali AR. Recent insights on the use of topical steroids in eosinophilic esophagitis. Expert Rev Gastroenterol Hepatol 2020;14:953-63. https://doi.org/10.1080/17474124.2020.1785869
  15. Laserna-Mendieta EJ, Casabona S, Savarino E, Perello A, Perez-Martinez I, Guagnozzi D, et al. Efficacy of therapy for eosinophilic esophagitis in real-world practice. Clin Gastroenterol Hepatol 2020;18:2903-11.e4. https://doi.org/10.1016/j.cgh.2020.01.024
  16. Rokkas T, Niv Y, Malfertheiner P. A network meta-analysis of randomized controlled trials on the treatment of eosinophilic esophagitis in adults and children. J Clin Gastroenterol 2021;55:400-10. https://doi.org/10.1097/MCG.0000000000001356